GlassScriptPhysician profile
Amanda M Reeves
NPI 1285927491
$2,698.14
in general payments reported to CMS, 2019-2025
36 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $550 · 2020: $1,108 · 2021: $1,026 · 2022: $14.95.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $354.06 | 2019-2021 | |
| Allergan, INC. | $249.09 | 2019-2020 | |
| Pfizer INC. | $209.19 | 2019-2021 | |
| Abbvie INC. | $197.72 | 2019-2021 | |
| Lilly USA, LLC | $174.93 | 2019-2021 | |
| Esperion Therapeutics, INC. | $174.02 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $149.27 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $112.39 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $105.42 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $98.12 | 2020-2021 | |
| Radius Health, INC. | $88.40 | 2020-2021 | |
| Novo Nordisk INC | $85.75 | 2020-2021 | |
| Hologic Sales and Service, LLC | $84.94 | 2019 | |
| Horizon Therapeutics Plc | $59.99 | 2020-2021 | |
| Shire North American Group INC | $59.67 | 2019 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $53.38 | 2020-2021 | |
| Genzyme Corporation | $51.05 | 2021-2022 | |
| Alkermes, INC. | $43.88 | 2020-2021 | |
| Glaxosmithkline, LLC. | $32.09 | 2019-2021 | |
| Eisai INC. | $28.79 | 2020-2021 | |
| Vanda Pharmaceuticals INC. | $28.57 | 2020 | |
| Neurocrine Biosciences, INC. | $27.74 | 2020-2021 | |
| Jazz Pharmaceuticals INC. | $24.56 | 2021 | |
| Astellas Pharma US INC | $21.75 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.98 | 2019 | |
| Merck Sharp & Dohme LLC | $17.73 | 2021 | |
| Lantheus Medical Imaging, INC. | $17.05 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.00 | 2021 | |
| Genentech USA, INC. | $15.41 | 2020 | |
| Bausch Health US, LLC | $15.23 | 2020 | |
| Janssen Pharmaceuticals, INC | $14.84 | 2020 | |
| Sanofi Pasteur INC. | $14.05 | 2019 | |
| Adlon Therapeutics L.P. | $13.94 | 2020 | |
| Fidia Pharma USA INC. | $13.65 | 2020 | |
| Hikma Pharmaceuticals USA | $12.90 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $12.59 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Reeves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.